Jamalpoor A, van Gelder CA, Yousef Yengej FA, Zaal EA, Berlingerio SP, Veys KR, Pou Casellas C, Voskuil K, Essa K, Ammerlaan CM, Rega LR, van der Welle RE, Lilien MR, Rookmaaker MB, Clevers H, Klumperman J, Levtchenko E, Berkers CR, Verhaar MC, Altelaar M, Masereeuw R, Janssen MJ (2021) Cysteamine-bicalutamide combination therapy corrects proximal tubule phenotype in cystinosis
H.YangS
SLC25A39 depletion inhibits subcutaneous xenograft growth in vivo To evaluate the effect of SLC25A39 on LUAD tumor growth in vivo, we established a xenograft model by subcutaneously injecting 2 10 6 A549 cellseither Cas9 control (Cas9C) or SLC25A39 knockout (koSLC25A39)into the left axilla of nude mice (n = 7 per group)
Immune Support: Interested in boosting immune system function
10.1152/japplphysiol.00990.2016 19 HoE.Karimi GalougahiK.LiuC.-C.BhindiR.FigtreeG